← 返回

一种非病毒 piggyBac 转座子介导的从人外周血原代 NK 细胞大规模制备 CAR-NK 细胞的方法

英文原题:A Nonviral piggyBac Transposon-Mediated Method to Generate Large-Scale CAR-NK Cells from Human Peripheral Blood Primary NK Cells.

查看英文原题

A Nonviral piggyBac Transposon-Mediated Method to Generate Large-Scale CAR-NK Cells from Human Peripheral Blood Primary NK Cells.

PubMed 2024/01/01(内容时间) Methods Mol Biol

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

基于其固有的抗肿瘤功能和独特的“现货型”潜力,经嵌合抗原受体(CAR)基因工程改造的人自然杀伤(NK)细胞,在治疗多种血液系统恶性肿瘤和实体瘤方面前景广阔。目前,大规模生产CAR-NK细胞主要依赖mRNA转染和病毒载体转导。但mRNA CAR-NK细胞的CAR表达不稳定,而病毒载体转导通常效率较低。本章介绍一种优化方案:通过电转使用piggyBac转座子系统制备CAR-NK细胞,并进一步利用人工抗原呈递饲养细胞大规模扩增这些工程化CAR-NK细胞。该方法可高效、稳定地改造人原代NK细胞,并提供足量工程化CAR-NK细胞,以供未来潜在临床应用。

展开英文摘要原文

With the inherent antitumor function and unique "off-the-shelf" potential, genetically engineered human natural killer (NK) cells with chimeric antigen receptors (CARs) bear great promise for the treatment of multiple hematological malignancies and solid tumors. Current methods of producing large-scale CAR-NK cells mainly rely on mRNA transfection and viral vector transduction.

However, mRNA CAR-NK cells were not stable in CAR expression while viral vector transduction mostly ended up with low efficiency. In this chapter, we described an optimized protocol to generate CAR-NK cells by using the piggyBac transposon system via electroporation and to further expand these engineered CAR-NK cells in a large scale together with artificial antigen-presenting feeder cells.

This method can stably engineer human primary NK cells with high efficiency and supply sufficient scale of engineered CAR-NK cells for the future possible clinical applications.

论文信息

作者
Du Z、Zhao T、Chen X、Zha S、Wang S
第一作者单位
Department of Biological Sciences, National University of Singapore, Singapore, Singapore.Singapore
通讯作者单位
Department of Biological Sciences, National University of Singapore, Singapore, Singapore. dbsws@nus.edu.sg.Singapore
文献类型
非美国政府资助研究
期刊
Methods in molecular biology (Clifton, N.J.)2024
原文标识
PubMed 38070120 · DOI 10.1007/978-1-0716-3593-3_18